Organometallics
Article
mL of Et2O was added dropwise via cannula. The pale yellow solution
was stirred under N2 for 18 h at room temperature before removing
the solvent in vacuo. The white solid was taken up in 38 mL of
toluene, and 1,1,1,5,5,5-hexafluoro-2,4-pentanedione (2.2 mL, 3.2 g,
15.5 mmol, 1.0 equiv) was added via syringe. The flask was sealed and
heated to 90 °C for 24 h. The solvent was removed via rotary
evaporation, and the crude product was purified by silica gel flash
chromatography, eluting with a gradient of ethyl acetate and hexane.
One pure fraction (0.54 g) was obtained, and a second fraction
required further purification by recrystallization from hexane, yielding
Anal. Calcd for C43H26F15IrN4: C, 48.00; H, 2.44; N, 5.21. Found: C,
47.37; H, 2.26,; N, 4.99.
Preparation of Ir(bt)2(NacNacF15) (8). Complex 8 was prepared
via the general method described for complex 7, using [Ir(bt)2(μ-Cl)]2
(49 mg, 0.038 mmol) and NacNacF15Li·Et2O (49 mg, 0.075 mmol, 2.0
equiv). We experienced difficulty separating a ca. 5% impurity of
NacNacF15H from this sample, by both recrystallization and
chromatography, but the free ligand impurity did not interfere with
subsequent electrochemical and optical spectroscopic measurements.
1
Yield: 59 mg (66%). H NMR (400 MHz, CDCl3) δ: 8.67 (d, J = 8.0
1
an additional 0.99 g. Combined yield: 1.53 g (23.5%). H NMR (400
Hz, 1H, ArH), 8.43 (d, J = 8.4 Hz, 1H, ArH), 8.05 (d, J = 7.2 Hz, 2H,
ArH), 7.71 (m, 2H, ArH), 7.62 (m, 2H, ArH), 6.97−7.07 (m, 5H,
ArH), 6.93 (s, 1H, ArH), 6.49 (t, J = 7.4 Hz, 1H, ArH), 6.45 (t, J = 7.6
Hz, 1H, ArH), 6.37 (t, J = 7.4 Hz, 1H, ArH), 6.32 (t, J = 7.2 Hz, 1H,
ArH), 5.80 (d, J = 7.2 Hz, 1H, ArH), 5.75 (d, J = 8.0 Hz, 1H, ArH),
5.67−5.73 (m, 2H, ArH), 5.47 (s, 1H, ArNC(CF3)CHC(CH3)NAr),
1.68 (s, 3H, CH3). 19F NMR (376 MHz, CDCl3) δ: −59.04 (s, 3F),
−62.64 (s, 3F), −62.68 (s, 3F), −62.74 (s, 3F), −63.00 (s, 3F). UV−
vis (THF): λ/nm (ε/M−1 cm−1) 271 (31 000), 314 (sh) (29 000), 324
(32 000), 409 (sh) (12 000), 421 (12 000). Anal. Calcd for
C47H26F15IrN4S2: C, 47.52; H, 2.21; N, 4.72. Found: C, 47.68; H,
2.21; N, 4.68.
MHz, C6D6) δ: 10.96 (br, s, 1H, NH), 7.45 (s, 1H, ArH), 6.79 (s, 2H,
ArH), 5.85 (s, 1H, ArNC(CF3)CHC(O)CF3). 19F NMR (376 MHz,
C6D6) δ: −62.67 (s, 6F), −63.62 (s, 3F), −77.16 (s, 3F).
Preparation of Ir(ppy)2(NacNacF12) (5). In the glovebox, solid
[Ir(ppy)2(μ-Cl)]2 (100 mg, 0.0933 mmol) was suspended in 2 mL of
THF in a scintillation vial. A solution of NacNacF12K (96 mg, 0.17
mmol, 1.8 equiv) in 2 mL of THF was added dropwise. The mixture
was stirred for 2 h at room temperature, after which the solvent was
removed in vacuo. The solid was extracted into 4 mL of toluene and
filtered through Celite. After removing the toluene in vacuo, the crude
product was washed with 1 mL of Et2O at −35 °C in the glovebox
freezer and then with 2 × 1 mL of pentane at room temperature before
drying in vacuo. Yield: 92 mg (52%). 1H NMR (600 MHz, CDCl3) δ:
9.10 (d, J = 6.0 Hz, 2H, ArH), 7.80 (t, J = 7.2 Hz, 2H, ArH), 7.63 (d, J
= 8.4 Hz, 2H, ArH), 7.32 (t, J = 6.3 Hz, 2H, ArH), 6.97−7.01 (m, 4H,
ArH), 6.83 (s, 2H, ArH), 6.41 (t, J = 7.2 Hz, 2H, ArH), 6.29 (t, J = 7.2
Hz, 2H, ArH), 5.74 (d, J = 7.2 Hz, 2H, ArH), 5.54 (s, 2H, ArH), 4.71
(s, 1H, ArNC(CH3)CHC(CH3)NAr), 1.60 (s, 6H, CH3). 19F NMR
(376 MHz, CDCl3) δ: −62.74 (s, 6F), −63.11 (s, 6F). UV−vis
(THF): λ/nm (ε/M−1 cm−1) 265 (45 000), 348 (15 000), 402
(14 000). Anal. Calcd for C43H29F12IrN4: C, 50.54; H, 2.86; N, 5.48.
Found: C, 50.49; H, 2.66; N, 5.41.
Preparation of Ir(ppy)2(NacNacF18) (9). Complex 9 was prepared
by the general method described for complex 7, using [Ir(ppy)2(μ-
Cl)]2 (110 mg, 0.103 mmol) and NacNacF18Li (132 mg, 0.207 mmol,
2.01 equiv). In this case the product was only sparingly soluble in
Et2O, and purification was achieved by washing with cold Et2O and
pentane. Yield: 143 mg (61.1%). 1H NMR (600 MHz, CDCl3) δ: 8.94
(d, J = 5.4 Hz, 2H, ArH), 7.92 (t, J = 7.2 Hz, 2H, ArH), 7.72 (d, J = 7.8
Hz, 2H, ArH), 7.43 (t, J = 6.0 Hz, 2H, ArH), 7.05 (s, 2H, ArH), 7.01
(d, J = 7.8 Hz, 2H, ArH), 6.85 (s, 2H, ArH), 6.46 (t, J = 7.5 Hz, 2H,
ArH), 6.32 (t, J = 7.2 Hz, 2H, ArH), 5.67 (s, 1H, ArNC(CF3)CHC-
(CF3)NAr), 5.60−5.63 (m, 4H, ArH). 19F NMR (565 MHz, CDCl3)
δ: −59.31 (s, 6F), −62.87 (s, 6F), −63.26 (s, 6F). UV−vis (THF): λ/
nm (ε/M−1 cm−1) 251 (41 000), 373 (9800), 418 (9200), 472 (sh)
(4900). Anal. Calcd for C43H23F18IrN4: C, 45.71; H, 2.05; N, 4.96.
Found: C, 45.42; H, 1.96; N, 4.88.
Preparation of Ir(bt)2(NacNacF12) (6). The title complex was
prepared analogously to complex 5, using [Ir(bt)2(μ-Cl)]2 (100 mg,
0.0771 mmol) and NacNacF12K (83 mg, 0.15 mmol, 1.9 equiv). Yield:
1
133 mg (78%). H NMR (400 MHz, CDCl3) δ: 8.63 (d, J = 8.0 Hz,
2H, ArH), 8.02 (d, J = 8.0 Hz, 2H, ArH), 7.68 (t, J = 7.0 Hz, 2H,
ArH), 7.58 (t, J = 7.0 Hz, 2H, ArH), 7.02 (d, J = 7.6 Hz, 2H, ArH),
6.99 (s, 2H, ArH), 6.94 (s, 2H, ArH), 6.44 (t, J = 7.4 Hz, 2H, ArH),
6.33 (t, J = 6.8 Hz, 2H, ArH), 5.85 (d, J = 7.6 Hz, 2H, ArH), 5.64 (s,
2H, ArH), 4.95 (s, 1H, ArNC(CH3)CHC(CH3)NAr), 1.62 (s, 6H,
CH3). 19F NMR (376 MHz, CDCl3) δ: −62.63 (s, 6F), −62.73 (s,
6F). UV−vis (THF): λ/nm (ε/M−1 cm−1) 273 (29 000), 312
(24 000), 323 (27 000), 409 (13 000), 494 (sh) (1200). Anal. Calcd
for C47H29F12IrN4S2: C, 49.78; H, 2.58; N, 4.94. Found: C, 49.77; H,
2.65; N, 4.79.
Preparation of Ir(bt)2(NacNacF18) (10). The title compound was
prepared via the general procedure described for complex 7, using
[Ir(bt)2(μ-Cl)]2 (100 mg, 0.0.0771 mmol) and NacNacF18Li (98 mg,
0.15 mmol, 2.0 equiv). Again, the product was purified by washing
1
with cold ether and pentane. Yield: 128 mg (66.8%). H NMR (600
MHz, CDCl3) δ: 8.45 (d, J = 8.4 Hz, 2H, ArH), 8.08 (d, J = 7.2 Hz,
2H, ArH), 7.76 (t, J = 7.8 Hz, 2H, ArH), 7.66 (t, J = 7.8 Hz, 2H, ArH),
7.03−7.06 (m, 4H, ArH), 6.98 (s, 2H, ArH), 6.49 (t, J = 7.2 Hz, 2H,
ArH), 6.36 (t, J = 7.5 Hz, 2H, ArH), 5.92 (s, 1H, ArNC(CF3)CHC-
(CF3)NAr), 5.73 (s, 2H, ArH), 5.69 (d, J = 7.2 Hz, 2H, ArH). 19F
NMR (565 MHz, CDCl3) δ: −59.48 (s, 6F), −62.82 (s, 6F), −62.94
(s, 6F). UV−vis (THF): λ/nm (ε/M−1 cm−1) 257 (44 000), 312 (sh)
(43 000), 323 (50 000), 405 (16 000), 431 (sh) (13 000). Anal. Calcd
for C47H23F18IrN4S2: C, 45.45; H, 1.87; N, 4.51. Found: C, 45.50; H,
1.79; N, 4.47.
Preparation of Ir(ppy)2(NacNacF15) (7). A general procedure was
followed for the preparation of all backbone-fluorinated complexes,
which is described in detail here. [Ir(ppy)2(μ-Cl)]2 (41 mg, 0.038
mmol) and NacNacF15Li·Et2O (49 mg, 0.075 mmol, 2.0 equiv) were
combined in 6 mL of toluene and sealed in a pressure vessel with a
Teflon screw cap. The mixture was heated at 90 °C for 24 h, giving a
red solution (in some cases small amounts of unreacted Ir(C∧N)
dimer are present). After cooling to room temperature the solution
was filtered through Celite and concentrated to dryness via rotary
evaporation. The solid was extracted into Et2O and filtered. The Et2O
was removed in vacuo, and the solid washed with pentane, giving the
Preparation of Ir(ppy)2(acNacF6) (13). This was prepared by the
general procedure described for complex 7, using [Ir(ppy)2(μ-Cl)]2
(100 mg, 0.0933 mmol) and acNacF6Li (54 mg, 0.19 mmol, 2.0 equiv).
The crude product was recrystallized from THF/pentane by vapor
1
diffusion, affording the product as 13·THF. Yield: 94 mg (57%). H
NMR (400 MHz, CDCl3) δ: 8.86 (d, J = 5.6 Hz, 1H, ArH), 8.62 (d, J
= 4.8 Hz, 1H, ArH), 7.80−7.94 (m, 2H, ArH), 7.74 (t, J = 7.6 Hz, 1H,
ArH), 7.54 (d, J = 7.6 Hz, 2H, ArH), 7.19−7.26 (m, 2H, ArH), 6.96
(d, J = 6.4 Hz, 1H, ArH), 6.83 (t, J = 7.6 Hz, 1H, ArH), 6.67 (m, 2H,
ArH), 6.51−6.57 (m, 3H, ArH), 6.45 (t, J = 7.2 Hz, 1H, ArH), 6.27 (d,
J = 7.6 Hz, 1H, ArH), 6.12 (d, J = 7.2 Hz, 1H, ArH), 5.99 (d, J = 8.0
Hz, 1H, ArH), 5.67 (s, 1H, PhNC(CF3)CHC(O)CH3), 5.36 (d, J =
6.8 Hz, 1H, ArH). 19F NMR (565 MHz, C6D6) δ: −60.67 (s, 3F),
−74.10 (s, 3F). UV−vis (THF): λ/nm (ε/M−1 cm−1) 262 (36 000),
295 (sh) (21 000), 348 (sh) (8600), 391 (sh) (6100), 425 (sh)
(4100). Anal. Calcd for C33H22F6IrN3O·THF: C, 51.99; H, 3.54; N,
4.92. Found: C, 51.82; H, 3.43; N, 4.86.
1
final product. Yield: 67 mg (83%). H NMR (400 MHz, CDCl3) δ:
9.03 (d, J = 6.0 Hz, 1H, ArH), 9.01 (d, J = 5.2 Hz, 1H, ArH), 7.86 (m,
2H, ArH), 7.70 (d, J = 8.4 Hz, 1H, ArH), 7.66 (d, J = 8.4 Hz, 1H,
ArH), 7.37 (m, 2H, ArH), 7.06 (s, 1H, ArH), 6.96−7.03 (m, 3H,
ArH), 6.86 (s, 1H, ArH), 6.83 (s, 1H, ArH), 6.44 (m, 2H, ArH), 6.33
(t, J = 7.4 Hz, 1H, ArH), 6.28 (t, J = 6.8 Hz, 1H, ArH), 5.67 (m, 2H,
ArH), 5.61 (s, 1H, ArH), 5.56 (s, 1H, ArH), 5.22 (s, 1H,
ArNC(CF3)CHC(CH3)NAr), 1.66 (s, 3H, CH3). 19F NMR (376
MHz, CDCl3) δ: −58.87 (s, 3F), −62.66 (s, 3F), −62.91 (s, 3F),
−63.10 (s, 3F), −63.19 (s, 3F). UV−vis (THF): λ/nm (ε/M−1 cm−1)
266 (51 000), 338 (sh) (17 000), 391 (14 000), 422 (sh) (11 000).
H
Organometallics XXXX, XXX, XXX−XXX